Latest ArticlesThe continuous proliferation of viral products, such as viral vector vaccines, CAR-T products produced by lentiviral transduction, and adenovirus-based gene therapy products, has presented novel challenges for manufacturing units and regulatory agencies in terms of quality control and supervision due to the complexity of production methods and diversity of products. To ensure the purity, activity, and other quality attributes of viral products, it is imperative to conduct inspections during the production and release processes. The infectious titer, as one of the key quality attributes, holds significant importance as it allows for the evaluation of safety and efficacy. This review provides a comprehensive summary of the principles and applications of existing methods for quantifying virus infectivity, including plaque assay, 50% tissue culture infectious dose, fluorescent focus assay, various polymerase chain reactions, flow cytometry, and nano-flow cytometry(nFCM). By introducing and comparing these methods, manufacturing companies and regulatory agencies can make informed decisions regarding the selection of appropriate techniques to ensure product quality in different application scenarios.
The active pharmaceutical ingredient in dry powder inhalers(DPIs) is usually an insulator with a small particle size that tends to exhibit significant electrostatic behavior in the preparation and usage stages of DPIs. It will cause a decrease in the flowability and an increase in adhesion of drug particles, which in turn will affect the content uniformity and the aerodynamic particle size distribution(APSD) after atomization, leading to a decrease in lung deposition and efficacy of drugs. This review introduces the generation of static electricity in DPIs, the influences of static electricity on the blending uniformity and APSD of DPIs and the commonly used methods for evaluating electrostatic potential to provide a reference for subsequent electrostatic research on DPIs.
The synthesis of the antiplatelet aggregation inhibitor tirofiban hydrochloride(1) has been optimized. Ethyl n-butylsulfonyl-L-tyrosinate(5) was synthesized from ethyl L-tyrosinate(4) by sulfonylation. After the substitution of 5 with 4-(pyridin-4-yl)butyl-4-methyl benzenesulfonate(3), followed by the hydrolysis with lithium hydroxide, N-n-butylsulfonyl-O-[4-(4-pyridyl)butyl]-L-tyrosine(6) was obtained. Then, 6 was reduced by hydrogen in the presence of Pd/C and salted with hydrochloric acid to obtain the target compound 1. The overall yield was 63.5%(based on 4) with purity of 99.80%, and ee value of 99.8%. The improved process has short steps with high product yield, economical and easily accessible raw materials, and mild and controllable reaction conditions, which is suitable for industrial production.
In order to control the quality of finerenone, this study synthesized five related substances, namely 4-(4-cyano-2-methoxyphenyl)-6-ethyl-2,8-dimethyl-5-oxy-1,4,5,6-tetrahydro-1,6-naphthyridin-3-carboxamide(related substance A), 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine(related substance B), 3-hydroxy-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridine(related substance C), 4-(4-aminocarbonyl-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxamide(related substance D), and 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,6-naphthyridin-3-carboxamide(related substance E). The chemical structures of these substances were confirmed by 1H NMR, 13C NMR and HRMS.
To determine the influence of different high inoculation densities on the expression level and quality of bispecific antibodies and strengthen the cell culture process, bispecific antibody cells were inoculated into a 3 L bioreactor at low, medium and high grades of high inoculation density[containing (10±1)×106, (15±1)×106 and (20±1)×106 cells per 1 mL, respectively] for fed-batch culture. The influences of different inoculation densities on antibody expression level and quality were evaluated. The results showed that compared with low grade of high inoculation density, the antibody expression levels of the intensified medium or high grade of high inoculation density process increased to 1.43 g/L, and there was no significant difference in antibody quality. Within the same culture period(16 d), on the premise of no influence on antibody quality and reduction of costs, medium grade of high inoculation density should be adopted for inoculation density, and the antibody expression level could be increased to 1.43 g/L, which was an 81% increase compared with the conventional process(0.79 g/L). Subsequently, the intensified medium grade of high inoculation density process was successfully scaled up to a 30 L bioreactor, providing valuable experience for subsequent antibody process development.
Based on the quality by design concept, the key risk variables in the formulation of valsartan capsules were identified through risk assessment. Using the original drug “Diovan” as a reference and consistency in dissolution behavior as the evaluation index, a single factor method was employed to investigate the impacts of the variables such as the disintegrant amount, the preparation method of the adhesive, the addition method of the solubilizer, the capsule shells from different manufacturers, and the particle size of API on the dissolution rate. The self-made valsartan capsules prepared with the optimized formulation and “Diovan” exhibited consistent dissolution behaviors in four different dissolution media.
The ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry(UPLC-QTOF-MS) and gas chromatography-mass spectrometry(GC-MS) methods were applied to systematically characterize the chemical constituents of turmeric extract. Based on Chinese Pharmacopoeia(2020 edition) VolumeⅠ, the quality control of curcuminoids in turmeric extracts was performed by UV and HPLC methods. The results showed that 44 components(including 28 curcuminoids, 10 sesquiterpenes and 6 others) and 9 volatiles were identified by UPLC-QTOF-MS and GC-MS, respectively. The results of quantitative analysis indicated curcumins were main components in extracts, which accounted for 65% among 10 batches. The significance of this study was to comprehensively reveal the chemical constituents of turmeric extract, which provided essential data for quality control and clinical application of the pharmaceutical dosage forms of turmeric extracts.
An HPLC method was established to determine eleven synthetic phosphatidylcholine(PC) and phosphatidylethanolamine(PE) phospholipids. Consideration of the structural characteristics and retention behaviors in chromatography of the phospholipids, C8 chromatography columns with pore sizes of 12 and 15 nm(120 and 150 Å) were connected in series for the first time. The serial sequence was Welch Topsil C8 column(4.6 mm×250 mm, 5 μm, 15 nm) at front and Ultimate XB C8 column(4.6 mm×250 mm, 5 μm, 12 nm) at back. The analysis was carried out in the gradient elution mode with water-methanol-acetic acid-triethylamine as mobile phase A, and methanol-isopropanol-acetic acid-triethylamine as mobile phase B. The results showed that the minimum separation degree of eleven synthetic PC and PE was 1.0. It was linear for seven synthetic PC phospholipids in the concentration of 0.1 - 1.0 mg/mL, and it was linear for four synthetic PC phospholipids in the concentration of 0.03 - 0.30 mg/mL. RSDs of precision were all less than 2.5%. And this separation method was successfully applied to the determination of synthesized phospholipids in two types of liposome injections and one excipient.
Polymers, dimers and monomers were separated by gel filtration chromatography, and the C1q enzyme-linked immunosorbent assay(ELISA) method was established. The specificity, precision and sensitivity of the method were verified, and the substance of anticomplementary activity in different batches of products were determined and compared. The results showed that when the coating concentration of C1q on the ELISA plate was 2 μg/mL and the dilution ratio of the secondary antibody was 30 000, the test sample exhibited a typical S-shaped binding curve in the concentration range of 1 - 50 000 μg/mL, with a linear interval of 10 - 400 μg/mL. The specificity and sensitivity of the method were good, with a precision test RSD(n=6) of 6.7%. The binding between the polymer and the complement molecule C1q was significantly higher than that of the dimer and polymer. Polymers were the substance for inhibiting complement activity in this product, and the C1q ELISA method could be used to directly compare the substance levels of anticomplementary activity in different products.
A HPLC-UV method was established to determine 15 related substances in tedizolide phosphate(1) bulk drug. The Welch Ultimate XBridge C18 chromatography column was used, and the analysis was carried out in the gradient elution mode with 0.01 mol/L ammonium dihydrogen phosphate and 0.01 mol/L ammonium dihydrogen phosphate aqueous solution(pH 5.5) as mobile phase A, and acetonitrile as mobile phase B. The detection wavelength was 235 nm. And another HPLC-UV method was established to determine the isomer impurity in 1 bulk drugs. The Daicel Chiralpak OJ-H chromatographic column was used, and the analysis was carried out with an isocratic elution mobile phase composed of n-hexane, ethanol and diethylamine in a volume ratio of 35∶65∶0.1. The detection wavelength was 300 nm. The results showed that it was linear for the relevant substances in the concentration range of 0.2 - 7.0 μg/mL, and the method recovery rate was 90% - 108%. The established method has good sensitivity, strong selectivity, and high repeatability, which can provide a reference for quality control research in 1.